Economic evaluation of low-dose rivaroxaban adding on aspirin for the patients with stable cardiovascular disease from the perspective of Taiwan national payers
9 November 2019 (09:00 - 13:00)
Organised by:
About the speaker

KU Leuven, Leuven (Belgium)
31 More presentations in this session
Assistant Professor T. Kinoshita (Tokyo, JP)
Access the full session
The Event
ESC Asia with APSC & AFC
9 November 2019
09:00 CET
